🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Superoxide Dismutase
250 IU

Other Ingredients

Cellulose Hypromellose Water, Purified Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one capsule daily or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Caution: For adults only. Keep out of reach of children.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Contains: wheat

🧪 Formulation Notes

Bluebonnet's Vegetarian SOD 250 IU vegetable capsules are formulated with the patented and clinically studied GliSODin, a vegetarian form of superoxide dismutase (SOD) from cantaloupe melon fruit extract protected by a gliadin complex to provide free radical protection and help support cellular health.

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, soybeans and sesame. Also free of corn, barley, rice, sodium and sugar.

Cantaloupe fruit extract

Free radical protection & cellular health

Non GMO

V Vegan

Additional Information

Store tightly closed in a cool, dry place.

V Vegan

Product Details

UPC / SKU 7 43715 00873 1
DSLD Entry Date 2024-09-25
Product Type Non-Nutrient/Non-Botanical
Form Capsule
Brand Bluebonnet
DSLD ID 317258
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.